CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Lipoprotein(a) in Alzheimer, Atherosclerotic, Cerebrovascular, Thrombotic, and Valvular Disease: Mendelian Randomization Investigation Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop Association of White Matter Hyperintensities and Cardiovascular Disease: The Importance of Microcirculatory Disease Metabolic Interactions and Differences between Coronary Heart Disease and Diabetes Mellitus: A Pilot Study on Biomarker Determination and Pathogenesis Clinical Risk Factors and Atherosclerotic Plaque Extent to Define Risk for Major Events in Patients Without Obstructive Coronary Artery Disease: The Long-Term Coronary Computed Tomography Angiography CONFIRM Registry Non-obstructive High-Risk Plaques Increase the Risk of Future Culprit Lesions Comparable to Obstructive Plaques Without High-Risk Features: The ICONIC Study Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease

Original Research2006 Mar 23;354(12):1264-72.

JOURNAL:N Engl J Med. Article Link

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

Cohen JC, Boerwinkle E, Mosley TH Jr et al. Keywords: PCSK9; Low LDL; CHD

FULL TEXT PDF